NCT06003218 2025-04-02
Dexmedetomidine-esketamine for Percutaneous Radiofrequency Liver Ablation
Peking University First Hospital
Phase NA Completed
Clinical Trials
21 trialsNCT06041425 2024-02-28
The Effects of Oxycodone Versus Sufentanil on Pain and Inflammatory Response After TACE
The First Affiliated Hospital with Nanjing Medical University
Phase 4 Completed
NCT03253133 2023-05-03
NIPOX
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 1 Completed
NCT05468671 2022-10-26
Clinical Application Value of Remazolam Combined With Sugammadex Sodium in Anesthesia for Endotracheal Surgery Under Bronchoscopy
Zhejiang Cancer Hospital
Phase 4 Completed
NCT03574792 2021-12-09
Gabapentin, Methadone, and Oxycodone With or Without Venlafaxine Hydrochloride in Managing Pain in Participants With Stage II-IV Squamous Cell Head and Neck Cancer Undergoing Chemoradiation Therapy
Roswell Park Cancer Institute
Phase NA Completed
NCT04726878 2021-11-09
ESP in Breast Surgery Due to Cancer
Medical University of Lublin
Phase 4 Completed
NCT03176121 2020-03-18
STOP Pain
Taiwan Mundipharma Pharmaceuticals Ltd.
Phase 4 Completed
NCT03176199 2020-03-18
A Study to Compare the Titration Efficacy and Safety of Control-released Oxycodone and Immediate-released Oxycodone in Patients With Moderate to Severe Cancer Pain
Taiwan Mundipharma Pharmaceuticals Ltd.
Phase 4 Completed
NCT01885182 2019-10-04
Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer Pain
Mundipharma (China) Pharmaceutical Co. Ltd
Phase 3 Completed
NCT03111186 2019-09-26
Ibuprofen Plus Acetaminophen Versus Oxycodone Alone After Hand Surgery
University of Southern California
Phase 2 Completed
NCT02660229 2018-11-19
SWITCH
Mundipharma Korea Ltd
Phase 4 Completed
NCT00513656 2018-10-23
A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer Pain
Mundipharma Research GmbH & Co KG
Phase 2 Completed
NCT02309437 2018-07-17
Early Use of Opioid in Radiation Mucositis
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Phase 2 Completed
NCT01675622 2018-05-21
Immediate-Release Oxycodone Capsules Study in Cancer Pain
Mundipharma (China) Pharmaceutical Co. Ltd
Phase 3 Completed
NCT01313780 2017-12-22
TOP
Mundipharma Korea Ltd
Phase 4 Completed
NCT01918098 2017-11-14
Targin for Non-cancer Pain
Mundipharma (China) Pharmaceutical Co. Ltd
Phase 3 Completed
NCT01675531 2016-12-16
A Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Mundipharma Korea Ltd
Phase 4 Completed
NCT02321397 2016-11-04
To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer Pain
Mundipharma Research GmbH & Co KG
Phase 2/3 Completed
NCT01809106 2015-12-24
CERP
Mario Negri Institute for Pharmacological Research
Phase 4 Completed
NCT00378937 2013-08-02
Oxycodone or Standard Pain Therapy in Treating Patients With Cancer Pain
National Cancer Institute (NCI)
Phase 4 Completed
NCT00637975 2011-02-02
Oxycodone and Pregabalin for the Treatment of Oncological Neuropathic Pain
Associazione Progetto Oncologia UMAN.A
Phase 2 Completed